CHASTLETON MEDICAL GROUP
NEWTON DRIVE, DURHAM
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 273 | 439 | 62.2% | |
| CKD 4 | 2008 | 235 | 349 | 67.3% | |
| CKD 5 | 2009 | 58 | 75 | 77.3% | |
| CKD 5 | 2010 | 27 | 31 | 87.1% | |
| CKD 5 | 2011 | 27 | 29 | 93.1% | |
| CKD 5 | 2012 | 24 | 26 | 92.3% | |
| CKD 5 | 2013 | 27 | 31 | 87.1% | |
| CKD003 | 2014 | 28 | 29 | 96.6% | |
| CKD003 | 2015 | 30 | 31 | 96.8% | |
| NM84 | 2016 | 28 | 36 | 77.8% | |
| NM84 | 2017 | 23 | 30 | 76.7% | |
| NM84 | 2018 | 23 | 32 | 71.9% | |
| NM84 | 2019 | 11 | 18 | 61.1% | |
| NM84 | 2020 | 13 | 19 | 68.4% | |
| NM84 | 2022 | 16 | 20 | 80.0% | |
| NM84 | 2023 | 19 | 24 | 79.2% |
